Dolores Ibarreta

2.9k total citations
41 papers, 1.3k citations indexed

About

Dolores Ibarreta is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Dolores Ibarreta has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 11 papers in Physiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Dolores Ibarreta's work include Alzheimer's disease research and treatments (7 papers), Ethics in Clinical Research (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dolores Ibarreta is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Ethics in Clinical Research (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dolores Ibarreta collaborates with scholars based in Spain, United Kingdom and Germany. Dolores Ibarreta's co-authors include Andreas Daxenberger, Michael M. Hopkins, Hilda Witters, Iris G. Lange, Heinrich H.D. Meyer, David Gurwitz, Matilde S. Ayuso, Roberto Parrilla, Eleni Zika and Heinrich Meyer and has published in prestigious journals such as Nature, Nature Biotechnology and Annals of Neurology.

In The Last Decade

Dolores Ibarreta

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dolores Ibarreta Spain 21 257 238 216 216 200 41 1.3k
Luciano Vittozzi Italy 23 503 2.0× 133 0.6× 291 1.3× 71 0.3× 240 1.2× 68 1.6k
Soon Young Han South Korea 26 1.0k 3.9× 135 0.6× 402 1.9× 162 0.8× 174 0.9× 56 1.8k
Karine Audouze France 26 593 2.3× 153 0.6× 743 3.4× 145 0.7× 87 0.4× 83 2.0k
Patrick J. Devine United States 19 235 0.9× 113 0.5× 364 1.7× 643 3.0× 260 1.3× 50 2.2k
Teresa Cabaleiro Spain 25 215 0.8× 139 0.6× 123 0.6× 68 0.3× 81 0.4× 57 1.3k
Sharon Munn Italy 17 1.1k 4.2× 79 0.3× 481 2.2× 84 0.4× 89 0.4× 24 2.3k
Mirjam Luijten Netherlands 29 889 3.5× 177 0.7× 1.1k 5.0× 89 0.4× 168 0.8× 102 2.8k
Vickie R. Walker United States 18 450 1.8× 125 0.5× 486 2.3× 311 1.4× 814 4.1× 33 2.1k
Patience Browne United States 20 1.0k 4.0× 114 0.5× 312 1.4× 105 0.5× 235 1.2× 37 2.0k
Yoon‐Jung Choi South Korea 19 223 0.9× 116 0.5× 226 1.0× 94 0.4× 78 0.4× 77 1.1k

Countries citing papers authored by Dolores Ibarreta

Since Specialization
Citations

This map shows the geographic impact of Dolores Ibarreta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolores Ibarreta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolores Ibarreta more than expected).

Fields of papers citing papers by Dolores Ibarreta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolores Ibarreta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolores Ibarreta. The network helps show where Dolores Ibarreta may publish in the future.

Co-authorship network of co-authors of Dolores Ibarreta

This figure shows the co-authorship network connecting the top 25 collaborators of Dolores Ibarreta. A scholar is included among the top collaborators of Dolores Ibarreta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolores Ibarreta. Dolores Ibarreta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massaro, Emanuele, Peter Newton, Grégoire Dubois, et al.. (2025). A 45-year global analysis of the spatial human forest nexus. Communications Earth & Environment. 6(1).
2.
Vicedo‐Cabrera, Ana M., Francesco Sera, Rochelle Schneider, et al.. (2020). A global attribution study on historical heat-related mortality impacts attributed to climate change.. 2 indexed citations
3.
Gosling, Simon N., David M. Hondula, Aditi Bunker, et al.. (2017). Adaptation to Climate Change: A Comparative Analysis of Modeling Methods for Heat-Related Mortality. Environmental Health Perspectives. 125(8). 87008–87008. 81 indexed citations
4.
Zika, Eleni, et al.. (2010). A European Survey on Biobanks: Trends and Issues. Public Health Genomics. 14(2). 96–103. 51 indexed citations
5.
Gurwitz, David, Cristina Rodríguez‐Antona, Katherine Payne, et al.. (2009). Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain. European Journal of Human Genetics. 17(8). 991–998. 32 indexed citations
6.
Rodríguez‐Antona, Cristina, David Gurwitz, José de León, et al.. (2009). CYP2D6 Genotyping for Psychiatric Patients Treated with Risperidone: Considerations for Cost–Effectiveness Studies. Pharmacogenomics. 10(4). 685–699. 27 indexed citations
7.
Gurwitz, David, Eleni Zika, Michael M. Hopkins, Sibylle Gaisser, & Dolores Ibarreta. (2009). Pharmacogenetics in Europe: Barriers and Opportunities. Public Health Genomics. 12(3). 134–141. 40 indexed citations
8.
Compagni, Amelia, et al.. (2008). Avoiding adverse drug reactions by pharmacogenetic testing: A systematic review of the economic evidence in the case of TPMT and AZA-induced side effects. International Journal of Technology Assessment in Health Care. 24(3). 294–302. 21 indexed citations
9.
Payne, Katherine, William G. Newman, David Gurwitz, Dolores Ibarreta, & Kathryn A. Phillips. (2008). TPMT Testing in Azathioprine: A ‘Cost-Effective Use of Healthcare Resources‘?. Personalized Medicine. 6(1). 103–113. 17 indexed citations
10.
Gaisser, Sibylle, et al.. (2008). Building effective institutional frameworks to support pharmacogenetic research: an international empirical analysis. International Journal of Biotechnology. 10(6). 552–552. 1 indexed citations
11.
Christidis, Panayotis, et al.. (2007). Modeling the Impact of Genetic Screening Technologies on Healthcare. Molecular Diagnosis & Therapy. 11(5). 313–323. 9 indexed citations
12.
Hopkins, Michael M., Dolores Ibarreta, Sibylle Gaisser, et al.. (2006). Putting pharmacogenetics into practice. Nature Biotechnology. 24(4). 403–410. 58 indexed citations
13.
Ibarreta, Dolores, et al.. (2005). The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. The Pharmacogenomics Journal. 6(1). 3–7. 60 indexed citations
14.
Ibarreta, Dolores, R Elles, Jean‐Jacques Cassiman, Emilio Rodríguez‐Cerezo, & Elisabeth Dequeker. (2004). Towards quality assurance and harmonization of genetic testing services in the European Union. Nature Biotechnology. 22(10). 1230–1235. 37 indexed citations
15.
Urcelay, Elena, Dolores Ibarreta, Roberto Parrilla, Matilde S. Ayuso, & Ángeles Martín‐Requero. (2001). Enhanced Proliferation of Lymphoblasts from Patients with Alzheimer Dementia Associated with Calmodulin-Dependent Activation of the Na+/H+ Exchanger. Neurobiology of Disease. 8(2). 289–298. 28 indexed citations
16.
Ibarreta, Dolores, et al.. (1999). Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells. Neuroreport. 10(5). 1035–1040. 18 indexed citations
17.
Bhagavan, Seetha, Dolores Ibarreta, Dawei Ma, Alan P. Kozikowski, & René Etcheberrigaray. (1998). Restoration of TEA-Induced Calcium Responses in Fibroblasts from Alzheimer's Disease Patients by a PKC Activator. Neurobiology of Disease. 5(3). 177–187. 11 indexed citations
18.
Ibarreta, Dolores, Elena Urcelay, Roberto Parrilla, & Matilde S. Ayuso. (1998). Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients. Annals of Neurology. 44(2). 216–222. 33 indexed citations
19.
Ibarreta, Dolores, et al.. (1997). Mutation analysis of chromosome 19 calmodulin (CALM3) gene in Alzheimer's disease patients. Neuroscience Letters. 229(3). 157–160. 4 indexed citations
20.
Ibarreta, Dolores, Teresa Gómez‐Isla, A. Portera‐Sánchez, Roberto Parrilla, & Matilde S. Ayuso. (1995). Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. Journal of the Neurological Sciences. 134(1-2). 146–149. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Vittozzi Breakdown of academic impact, for papers by Soon Young Han Breakdown of academic impact, for papers by Karine Audouze Breakdown of academic impact, for papers by Patrick J. Devine Breakdown of academic impact, for papers by Teresa Cabaleiro Breakdown of academic impact, for papers by Sharon Munn Breakdown of academic impact, for papers by Mirjam Luijten Breakdown of academic impact, for papers by Vickie R. Walker Breakdown of academic impact, for papers by Patience Browne Breakdown of academic impact, for papers by Yoon‐Jung Choi
Rankless by CCL
2026